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Abstract
In vitro fertilization (IVF) has become a standard treatment for subfertility after it was demonstrated to be of
value to humans in 1978. However, the introduction of IVF into mainstream clinical practice has been accom-
panied by concerns regarding the number of multiple gestations that it can produce, as multiple births present
significant medical consequences to mothers and offspring. When considering IVF as a treatment modality,
a balance must be set between the chance of having a live birth and the risk of having a multiple birth. As IVF
is often a costly decision for patients—financially, medically, and emotionally—there is benefit from esti-
mating a patient’s specific chance that IVF could result in a birth as fertility treatment options are contemplated.
Historically, a patient’s “chance of success” with IVF has been approximated from institution-based statistics,
rather than on the basis of any particular clinical parameter (except age). Furthermore, the likelihood of IVF
resulting in a twin or triplet outcome must be acknowledged for each patient, given the known increased
complications of multiple gestation and consequent increased risk of poor birth outcomes. In this research,
we describe a multivariate risk assessment model that incorporates metrics adapted from a national 7.5-year
sampling of the Human Fertilisation & Embryology Authority (HFEA) dataset (1991–1998) to predict repro-
ductive outcome (including estimation of multiple birth) after IVF. To our knowledge, http://www.for-
myodds.com is the first Software-as-a-Service (SaaS) application to predict IVF outcome. The approach also
includes a confirmation functionality, where clinicians can agree or disagree with the computer-generated
outcome predictions. It is anticipated that the emergence of predictive tools will augment the reproductive
endocrinology consultation, improve the medical informed consent process by tailoring the outcome assess-
ment to each patient, and reduce the potential for adverse outcomes with IVF.
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nIntroduction
The decision to embark on the IVF journey is often accom-
panied by substantial financial and emotional stress. IVF
patients therefore need a good understanding of their own
chance that IVF might result in a birth before they finalize
any treatment decision [1], although current efforts to pro-
vide this information early in the evaluation are typically
based on cumulative clinic-specific data from IVF patients
of similar age who previously attempted IVF at that insti-
tution. However, especially for older women, the outcome
of the first IVF cycle is not predictive of subsequent IVF
success [2], irrespective of where the treatment is offered
later [3].
It is important for IVF providers to explain statistics on
treatment outcomes and associated risks in an understand-
able way, so that patient expectations are not set unreal-
istically [4]. If this is not communicated accurately and
effectively, patients may become discouraged and stop
treatment. The need to develop a more sophisticated
mechanism to estimate IVF outcome at the individual
level can be reflected in drop-out rates among IVF
patients. For example, during the study interval for our
UK-based investigation, the average IVF patient comple-
ted only two cycles of treatment before either succeeding
(in a minority of cases) or dropping out of IVF altogether
[5]. There is no reason to believe that this circumstance is
confined to IVF patients within this jurisdiction. At the
same time, those who succeed with IVF may be unaware
of the intrinsic risk of multiples even with “conservative”
single embryo transfer [6], and unfamiliar with this risk
increasing with each additional embryo transferred. Those
who delay treatment likewise may be unaware of their
declining chances of IVF success with each passing year.
As a component of informed consent, patients and clini-
cians should welcome knowing the likelihood of having
twins (or higher order multiple gestation) because of com-
plications associated with such deliveries [7]. Moreover,
the now widespread practice of transferring multiple
embryos has been associated with an exponential increase
in multiple pregnancies throughout the world [6].
Although embryo transfer policy changes in the UK resul-
ted in a nearly 60% decline in three-embryo transfers, the
number of two-embryo transfers increased by about the
same percentage, and the number of single-embryo trans-
fers remained stable between 1992 and 2007 [8]. In USA
between 2003 and 2009, although the percentage of IVF
triplets declined by 2.3% to 4.8% across all age groups,
the percentage of twins has remained relatively constant
at 14.8% to 33.5% [9].
Unfortunately, iatrogenic multiple gestation is associated
with increased perinatal and maternal morbidity and mor-
tality rates, all of which present considerable medical,
social and health-related economic burdens on families
and healthcare systems [10–12]. The financial and emo-
tional costs of IVF treatment can be quite high, and, for
some couples, prohibitive. Given the elective nature of
assisted fertility treatments, IVF clinics often compete in
terms of their “per cycle” success rates. These combined
circumstances enhance the pressure, as seen in the UK,
USA and elsewhere, to increase the number of transferred
embryos (per cycle). This practice has sometimes been
followed by national mandates limiting such practices, but
often with a significant delay.
Against this background, more structured attempts to esti-
mate reproductive outcome after IVF have been devel-
oped [13]. Treatment-specific factors have been identified
to provide an accurate assessment of whether a patient has
low or high risk of a successful outcome following IVF,
although the initial approach was acknowledged to require
further external validation. Our investigation extends this
area of research by using an even larger population sam-
ple, gathered over a study interval of greater duration. We
report an externally validated methodology for reliably
predicting individual patient outcomes, including the
chances of delivering a livebirth and the conditional prob-
ability (given a livebirth) of having a multiple birth at var-
ious times in the future. The application [http://www.for-
myodds.com] has subsequently been refined as an online
predictive tool designed to help clinicians counsel patients
who are contemplating IVF.
Methods
Data origin and tabulation
Data were derived from the Human Fertilisation and
Embryology Authority (HFEA) assisted conception reg-
istry (UK), with permission granted by past HFEA chair-
persons to the first author of this paper (CAJ). Since 1991,
all IVF cycles initiated at licensed fertility treatment cen-
tres in the UK have been registered, and data on patient
demographics, reproductive history, clinical characteris-
tics of the IVF cycle, and birth outcomes were recorded
by parliamentary mandate. The present analysis used
anonymous registry data from July 1st 1991 to Dec 31st
1998. While the dataset used for this analysis is more than
a decade old, the proportional odds of an IVF pregnancy
resulting in multiple births, particularly following multi-
ple embryo IVF transfer practices, has not changed sig-
nificantly in the UK.
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In the period examined, 93,495 individual women and
couples underwent a total of 174,418 cycles of IVF in 68
clinics. Cycles were excluded from analysis if treatment
was abandoned before embryo transfer (n=3,274). Two
unique samples, a model development and a model vali-
dation, were employed for each of two models. One model
predicted the probability of having a live birth and the
other estimated the conditional probability of having a
multiple birth (given any live birth) over time. Note that
“live birth”, as defined by the HFEA, is in fact a “healthy
baby” rate, as in any pregnancy from which an infant was
born alive and remained viable for at least 28d. This HFEA
definition is at variance with that of the World Health
Organization (i.e. any born human being who demon-
strates independent signs of life, including breathing, vol-
untary muscle movement, or heartbeat [14]).
Predicting a livebirth and multiple births from IVF
To model the predicted probability of achieving a livebirth
after IVF, a random sample of 14,167 cycles was selected.
This sub-set represented a low enough percentage of all
cycles that there were no instances of patients re-entering
treatment for subsequent IVF cycles (e.g., one cycle = one
patient). After developing this model, a random sample of
71,415 novel cycles was selected on which to perform
validation analyses. To model the predicted probability of
having a multiple birth given any livebirth (in the case of
multiple births, given at least one livebirth surviving at
least 28d), cycles were first excluded where they did not
result in a live birth (n= 147,792). The remaining sample
of IVF cycles was next evenly and randomly divided into
a development sample and a validation sample (each class
n=13,313). Two predictive models were thus created: one
estimating the probability that an IVF cycle would result
in a live birth, and another, modelled over time, estimating
the conditional probability that an IVF cycle would result
in a multiple birth, given any birth. For the first model,
after exclusions, variables were stratified that were likely
to be associated with the success of an IVF cycle and could
be self-reported by the patient. These variables included:
maternal age, number of previous pregnancies, number of
previous miscarriages, number of previous livebirths
(defined in this case as any previous baby born alive,
stratified separately for natural vs. IVF conceptions),
Table 1:
Odds of live birth (n= 13,222)
Variable
  Odds Ratio
  95% Confidence Interval
 
Age < 1.0
< 2.0
1.00
1.00 }
χ2*
(0.00, 999.74)
Age
2 (0.79, 1.32)
Age
3 (1.00, 1.00)
Age cubic spline term (1.00, 1.00)
Years infertile [<1.0]* (0.96, 0.99)
Number previous IVF cycles < 1.0 *
< 2.0 *}χ2* (0.60, 0.73)
Previous IVF spline term (1.30, 1.70)
Number previous live births [<2.0]* (1.05, 1.22)
History of endometriosis [<1.0]* (0.71, 0.85)
History of miscarriage [<1.0]* (0.52, 0.85)
History of ectopic pregnancy [<1.0]* (0.05, 0.53)
If 1 embryo is transferred Reference
If 2 embryos are transferred [<4.0]* (2.41, 3.74)
If 3 embryos are transferred
  [<4.0]*
  (2.89, 4.44)
 
*
p< 0.01; ORs in brackets are generalised to a range in order to protect their proprietary novelty.
Table 2:
Odds of multiple birth, among cycles ending in live birth (n= 12,541)
Variable
  Odds Ratio
  95% Confidence Interval
 
Age < 1.0 *
< 1.0 *}χ2* (0.96, 0.99)
Age linear spline term (0.89, 0.96)
Years infertile 1.00
0.97}χ2† (0.97, 1.05)
Years infertile linear spline term (0.92, 1.01)
Number previous IVF cycles [<1.0]* (0.89, 0.96)
History of endometriosis [<1.0]* (0.81, 0.95)
History of miscarriage [<0.5]* (0.28, 0.51)
History of ectopic pregnancy [<1.0] (0.02, 1.09)
If 1 embryo is transferred Reference
If 2 embryos are transferred [<20]* (6.73, 21.37)
If 3 embryos are transferred
  [<20]*
  (11.14, 35.20)
 
*
p< 0.01; ; ORs in brackets are generalised to a range in order to protect their proprietary novelty.
†
p< 0.05
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nduration of infertility, number of prior IVF cycles, history
of endometriosis, tubal disease, or ectopic pregnancy, and
the number of embryos transferred in the index cycle.
Statistical analysis
To determine which variables would be included in the
final statistical model, univariate logistic regressions were
performed to determine the unadjusted association
between each variable and the odds of having a livebirth.
For continuous variables (i.e., maternal age), livebirths
were graphed by the predictor and fitted to a lowness curve
to visualize whether linear or cubic splines might be
appropriate. To determine optimal modelling for each pre-
dictor variable, several regressions were performed using
Akaike Information Criteria (AIC) and Bayesian Infor-
mation Criteria (BIC) from which the most appropriate
model was selected. Similarly, models were tested with
interaction terms between predictor variables and mater-
nal age. Variables were only included in the final predic-
tive model if they were statistically significant.
The final model included maternal age (with a cubic spline
at maternal age 29), number of years of involuntary child-
lessness (continuous), number of previous IVF cycles
(with a linear spline at 1 cycle), number of previous natural
live births (continuous), history of miscarriage (binary),
history of endometriosis (binary), and history of ectopic
pregnancy (binary). The number of embryos transferred
was included in the model using dummy variables and was
limited to 1, 2, or 3 embryos. This configuration was
chosen because during the study interval, no more than 3
embryos were permitted to be transferred in any given
cycle (in compliance with HFEA policy). The predicted
probability of success was thereby tested and structured
to be dependent on the number of embryos transferred.
The final model was fitted using logistic regression,
whereupon the log odds were translated into predicted
probabilities of having a livebirth. There was no multi-
collinearity in the model, as assessed by a variance infla-
tion factor (VIF) test, and a Hosmer-Lemmeshow good-
ness of fit analysis demonstrated good model fit.
Similar model development methods were used to predict
the conditional probability of an IVF cycle resulting in a
multiple birth (twins or higher order), given any live birth.
We tested the same variable set and selected variables
Table 3:
Representative IVF cases and predicted reproductive outcome probabilities, based on number of embryos transferred
(ET)
Patient characteristics If 1 ET If 2 ET If 3 ET
Age
 
#yrs sub-
fertile
 
#prior
IVF
cycles
 
#prior
natural
live
births
 
Hx endo-
metrio-
sis? (1=
yes)
 
Hx mis-
car-
riage?
(1= yes)
 
Hx
ectopic?
(1= yes)
 
prob
birth
 
prob
mult, if
birth
 
prob
birth
 
prob
mult, if
birth
 
prob
birth
 
prob
mult, if
birth
 
40 6 1 0 0 0 1 1.13 0.2 3.33 2.37 3.95 3.86
42 7 1 0 1 0 0 4.81 1.11 13.16 11.89 15.33 18.23
31 5 0 0 1 1 0 8.25 1.1 21.24 11.76 24.37 18.04
30 9 2 0 0 0 0 6.73 2.26 17.79 21.74 20.54 31.44
38 3 0 0 0 0 0 5.53 1.89 14.93 18.74 17.33 27.58
25 8 0 0 0 0 0 6.31 3.05 16.81 27.4 19.45 38.39
39 2 0 3 0 0 0 7.24 1.69 18.97 17.09 21.86 25.4
34 8 0 0 0 0 0 9.17 2.46 23.25 23.23 26.58 33.32
32 3 0 0 0 0 0 11.02 2.75 27.09 25.35 30.74 35.92
33
  2
  0
  4
  0
  0
  0
  12.24
  2.67
  29.5
  24.75
  33.33
  35.19
 
Table 4:
Split sample validation: Predicted probabilities from ForMyOdds.COM compared to actual percent of live births and
multiple births in the validation samples
Predicted probability of live birth
  Percent of cycles resulting in birth
  Predicted probability of multiple
birth
 
Percent of live births resulting in
multiples
 
0.0 to 5.0 3.3 0.0 to 5.0 1.8
5.0 to 9.9 7.2 5.0 to 9.9 8.8
10.0 to 14.9 12.3 10.0 to 14.9 13.5
15.0 to 19.9 17.2 15.0 to 19.9 20.9
20.0 to 24.9 22.6 20.0 to 24.9 25.4
25.0 to 29.9 26.7 25.0 to 29.9 27.2
30.0 or greater 29.7 30.0 to 34.9 33.7
35.0 to 39.9 37.5
   
40.0 or greater
  37.8
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regression models, and thereby determined the best char-
acterization of the predictor variable using AIC and BIC,
as previously described. When stratified by number of
embryos transferred (1, 2 or 3) in the index cycle, the final
multivariate logistic regression model included: maternal
age (with a linear spline at maternal age 35), number of
years of involuntary childlessness (with a linear spline at
5 years), number of previous IVF cycles, history of mis-
carriage (binary), history of endometriosis (binary), and
history of ectopic pregnancy (binary). Regression diag-
nostic tests demonstrated no multicollinearity (VIF test)
and good model fit (Hosmer-Lemmeshow).
 
 
Validation of model
The predictive models so created were validated in a sep-
arate sampling of IVF cycles, but was the same for each
sample pool. To the appropriate validation sample the
regression model was applied, and predicted probabilities
were calculated for each IVF cycle. Each model’s dis-
crimination was then assessed by measuring the area
under the curve of receiver operator characteristics
(AUROC) and its calibration by stratifying cycles into 5%
increments of predicted probability. Finally, we calculated
the true percentage of cycles that resulted in livebirths for
each stratum. All analyses were conducted using STATA
Version 9. Predicted odds ratios were then summarised
more generally in [brackets] in order to protect the pro-
prietary aspects of each respective model.
Results
Clinical characteristics
The ForMyOdds.com predictive ‘livebirth’ model was
developed using a sample of 14,167 IVF cycles, the
approximate the capacity of 15 IVF clinics over any given
year. Patients in this analysis were women who ranged in
age from 20 to 44 (mean±SD=33.8±4.3) years. Just under
half of these patients (45.5%) reported previous preg-
nancy, 19.0% reported a previous natural livebirth, and
5.7% reported a previous IVF-conceived livebirth. A his-
tory of ≥1 miscarriages was reported by 3%, and 1%
reported a history of ectopic pregnancy. Many patients had
a history of endometriosis (41.1%) and 9.5% reported
tubal disease. Patients described a wide range of time dur-
ing which they had been trying unsuccessfully to conceive
(range: 0–20; mean±SD= 5.5±3.6 years). The index IVF
cycle was their first for 28.3% of patients, the second for
26.6%, the third for 18.9%, and the forth or higher for
26.2% (range: 4–23 cycles).
 
 
The predictive ‘multiple birth’ model was developed
using a sample of 13,313 IVF cycles resulting in a live-
Figure 1. 
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nbirth. Because these cycles were selected from the popu-
lation of ‘successful’ IVF cycles, patient demographics
and clinical characteristics differed slightly. Women were
relatively young in this population (mean±SD
age=32.9±4.0 years). Under half (45.2%) reported previ-
ous pregnancies, 20.9% reported a previous natural live
birth, and only 7.3% reported a previous IVF-conceived
live birth. Three percent had a history of miscarriage and
less than 1% had a history of ectopic pregnancy. Mean
±SD duration of infertility was 5.2±3.3 years. In contrast
with the first sample, half of the index cycles were the
patients’ first (50.5%), 25.0% the second, 12.6% the third,
and only 11.9% were the fourth or higher (range 4–23
cycles) cycles, respectively.
Assessment of predictive probability
Overall, 18.9% of cycles resulted in a live birth (13.8%
singleton, 4.6% twins, 0.5% triplets). Three sets of quad-
ruplets were reclassified or removed from the dataset by
the HFEA and an additional set was removed as on further
audit it was found to be entered by one clinic in error.
Therefore, triplets were the highest order of multiple births
in this analysis. A cycle was more likely to result in a live
birth if the patient was younger, reported more previous
live births, experienced fewer years of being unable to
conceive, went through fewer previous IVF cycles, repor-
ted no history of miscarriage, ectopic pregnancy, or endo-
metriosis, and if more embryos were transferred (see
Table 1).
Amongst cycles that resulted in a livebirth, 72.2% were
singleton births, 24.9% were twin births, and 2.9% were
triplet births. The factor that most strongly affected the
conditional probability of having a multiple birth was
having 2 or 3 embryos transferred. Births were less likely
to be multiple if the patient was older, experienced more
years of not being able to conceive, reported more previ-
ous cycles of IVF, or reported a history of miscarriage,
ectopic pregnancy, or endometriosis (see Table 2). Table
3 presents examples of cases from the HFEA registry and
their predicted probability of birth and multiple births.
Both ‘livebirth’ and ‘multiple births’ models showed good
discrimination, with AUROC’s of 0.635 and 0.618,
respectively. Also, both models demonstrated very good
calibration (see Table 4). There was a slightly better cali-
bration in the ‘livebirth’ as compared with ‘multiple
births’ models, and slightly diminished calibration at the
ceiling of each model, compared to the lower and mid-
range of predicted probabilities. This means that the model
is most accurate for the general population who have a low
to average chance of achieving a livebirth. The “live-
births” model slightly overestimates the livebirth rate
among women who were predicted to have a 30% or
greater chance of a livebirth. Similarly, the “multiple
Figure 2. 
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nbirths” model slightly overestimates the chance of actually
delivering multiples among the population of women with
a 40% or higher predicted probability of multiple births.
Among the mid-range, the model slightly underestimates
the chance of a multiple birth. Nonetheless, where differ-
ences exist between actual and predicted probabilities, the
variation remained <3% (in most instances, it was much
less than this; see Table 4).
 
 
Electronic access to modelling (via internet)
These models have been developed into a openly available
online tool that is intended to be used by clinicians to assist
patients understand their individual likelihood of IVF suc-
cess and, indeed, multiple births before undergoing IVF.
This website was commissioned in January 2008 as a
patient education tool, to help in the decision to undergo
IVF either for the first time, whether to continue with
additional cycles of IVF following a failed cycle, the con-
sequences of delaying treatment (or, stated another way,
the benefits of expeditious treatment) and how many
embryos one should request to be transferred on each suc-
cessive cycle. Figures 1–5 show screen shots of the
sequential steps to be performed by clinicians and other
healthcare personnel, in order to arrive at results that are,
at the end of each analysis, personalised to the individual
circumstances of every IVF patient. The ‘Fast Forward-
ing’ feature of ForMyOdds.COM illustrated in Figure 4
allows for predictions to be made long before the patient
undergoes additional treatments. Under such circumstan-
ces, the declining probability of conception is highlighted
over time, underscoring the importance of early interven-
tion. The models were further (externally) validated in ad
hoc analyses conducted at The Sims Institute (Dublin) and
at University of Michigan (Ann Arbor) to ensure consis-
tency with current medical practice. This validation pro-
vided a key development feature to our models; namely,
the inclusion of a screenshot at the end of each ‘IVF Suc-
cess Test’ that asks whether the clinician agrees or disa-
grees with the predicted odds (Figure 5). Using For-
MyOdds.COM, clinicians can rapidly show patients their
individual predicted probabilities that depend in great part
on how many embryos are transferred. It is anticipated that
this process can help guide the conversation on embryo
transfer and manage realistic expectations concerning IVF
success against the risks of multiple births and failing to
complete a family in the expected timeframe.
Discussion
ForMyOdds.COM predicts individualised chances of ach-
ieving a livebirth and multiple births using formulae that
were developed using the largest available population-
based dataset of IVF treatments and outcomes. Addition-
ally, the software calculates the chances of livebirths and
Figure 3. 
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nmultiple births using a ‘Fast Forwarding’ function, at
defined future time points. First reported in July 2008
[15], this approach represents the first time an ex ante
approach was utilised to predict IVF treatment success. It
is anticipated that clinicians and patients alike may benefit
from improved accuracy and transparency in predicting
reproductive outcome.
As a counselling aid, this approach educates patients about
the impact of age on reproductive outcome, and encour-
ages early evaluation of fertility potential. Given that IVF
success is well known to be age-dependent [16–18],
patients who seek such treatments may be under financial,
clinical, or time pressures that might otherwise interfere
with the possibility of receiving early intervention.
Indeed, the results of our analysis support contemporary
findings that livebirth rate increases significantly when
additional embryos are transferred to certain populations
of women [19]. Yet, in some cases (i.e., female age 33,
infertility duration of 2yrs, no prior IVF, 4 previous live-
births), doubling the livebirth rate with an extra embryo
comes at the cost of a 10–fold increase in the risk of mul-
tiple gestation (predicted probability of livebirth = 12.2%
if 1 embryo is transferred vs. 29.5% if 2 embryos are
transferred; predicted probability for multiple gestation =
2.7% if 1 embryo is transferred vs. 24.8% if 2 embryos are
transferred). Moreover, including a third embryo at trans-
fer to individuals who would otherwise have only received
two, resulted in only a small increase in odds of a livebirth
at the expense of a substantial increase in the predicted
probability of multiple gestation. Interestingly, this was
not predicted to be true in all clinical circumstances, and
for the small percentage of patients who might otherwise
not have attained a livebirth with single embryo transfer,
the trade-off needs to be understood in consultation with
their doctor according to individual patient preference.
Our results highlight why individualised statistics are
essential for counselling, as actual IVF success depends
on numerous individual factors that are impossible ascer-
tain from aggregate “success rate” data generally available
from clinics.
As a variation of disease progression modelling for
description of impact of age on reproductive outcome,
ForMyOdds.COM also presents the consequences of
delaying treatment by 1 year or 5 years, and places the
importance of early intervention in sharp relief. When
presented as tangible odds of success, it is hoped that the
patient may seek services earlier than they might have
done if they were unaware of the consequences of con-
tinuing to delay parenthood. As a clinical research tool,
ForMyOdds.COM also collects anonymised doctor- and/
or patient-reported usage data concerning the specific
drugs being prescribed. It is hoped that this information
can be used for research purposes to examine case-mix
patterns and to establish additional links between treat-
Figure 4. 
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nments and outcomes. Not surprisingly, the results of this
study indicate that the success of IVF is greatest in
younger women during their first cycle of treatment. This
is likely because first presenters are more likely to be part
of the more fertile population as compared with those with
a long history of inability to conceive [3].
Although this approach demonstrates the value of person-
alised information, the models do have limitations. For
example, predictions generated from this model could not
present the variability of individual results (e.g. 95% con-
fidence intervals). As such, predictions of odds are pre-
sented as average estimates only. In our study population,
18.9% of IVF cycles resulted in a livebirth. Increasing the
number of embryos transferred predictably increased this
probability, but at a heightened risk of multiple births.
Such a balance is invariably weighted differently accord-
ing to various patient and treatment cases, and should not
be generalised according to just one discriminating vari-
able (e.g., age), but rather according to the interaction
among all relevant variables. Moreover, the model cannot
be generalized to women over age 44, because the HFEA
dataset did not include women above this age. Finally, the
time scale for the database (1991–1998) is such that it pre-
dated the HFEA directive to limit the number of embryos
transferred to 2 embryos per cycle in women 40 years of
age and younger. As such, different treatment policies
existed in the UK during the time period of analysis with
only a minority of clinics having a ‘two embryo transfer
policy’ and very few clinics performing elective single
embryo transfer. To this end, our predictions based on
single embryo transfers must be regarded with a certain
degree of caution, as it was assumed that the vast majority
of these were non-elective single embryo transfers (i.e.,
only one embryo was available for transfer, an a priori
poor prognostic indicator).
It should be acknowledged that the HFEA definition for
“livebirth” incorporates the neonatal period of 28d. Thus,
the model’s prediction of this outcome should be consid-
ered according to this taxonomy and explained carefully
to all users. Some countries may not reliably register
babies who die within the first 24h of birth, or may place
limits based on birth weight or gestational age in vital sta-
tistics [20]. However, we consider this difference as a
refinement to the extent that IVF patients would actually
prefer to access odds that their baby will be born alive and
healthy (not just alive only), an endpoint which this model
uniquely delivers.
Neonatal survival has generally improved since the time
of the HFEA data contributing to this study, and specific
neonatal outcomes may vary according to birth multiplic-
ity, between hospitals, with certain IVF techniques, or by
other important characteristics not currently embraced by
this model. For these reasons, our model’s accuracy in
Figure 5. 
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npredicting IVF birth outcomes may vary. To address this
limitation, the model can be modified to incorporate local
IVF and neonatal outcomes data and prospectively
improve the model’s predictive performance on an on-
going basis. And finally, while this dataset is from 1991–
1998, IVF policy changes that have led to changes in mul-
tiple birth rates in the UK and USA are not expected to
affect the accuracy of model outputs provided that the
inputs are within realistic ranges used in model develop-
ment and validation.
Conclusions
Patients are increasingly becoming active participants in,
rather than subjects of, medical treatments. The results of
the present study support algorithmic and personalized
approaches to health care delivery generally, with a topic
such as IVF providing an early test-case. When used for
predictive informational purposes, it is hoped that the
methodology behind ForMyOdds.com may be general-
ised to other treatments and diseases for which predictive
weightings have been reliably studied and externally vali-
dated. It is further hoped that ForMyOdds.com will assist
in presenting numerically-based reasons for patients
demanding early diagnosis and optimal treatments for
their individual circumstances.
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